| 1. |
Ergan B, Akgun M, Pacilli AMG, et al. Should I stay or should I go? COPD and air travel. Eur Respir Rev, 2018, 27(148): 180030.
|
| 2. |
李松林, 吳堅, 梅亮, 等. 中國民用航空衛生保障工作的現狀思考與展望. 空軍醫學雜志, 2011, 27(1): 8-20.
|
| 3. |
Aerospace Medical Association, Aviation Safety Committee, Civil Aviation subcommittee. Cabin cruising altitudes for regular transport aircraft. Aviat Space Environ Med, 2008, 79(4): 433-439.
|
| 4. |
Aerospace Medical Association Medical Guidelines Task Force. Medical Guidelines for Airline Travel, 2nd ed. Aviat Space Environ Med, 2003, 74(5 Suppl): A1-A9.
|
| 5. |
Shrikrishna D, Coker RK, Air Travel Working Party of the British Thoracic Society Standards of Care Committee. Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations. Thorax, 2011, 66(9): 831-833.
|
| 6. |
Dine CJ, Kreider ME. Hypoxia altitude simulation test. Chest, 2008, 133(4): 1002-1005.
|
| 7. |
Lee AP, Yamamoto LG, Relles NL. Commercial airline travel decreases oxygen saturation in children. Pediatr Emerg Care, 2002, 18(2): 78-80.
|
| 8. |
Ahmedzai S, Balfour-Lynn IM, Bewick T, et al. Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations. Thorax, 2011, 66(Suppl 1): i1-i30.
|
| 9. |
Harding RM, Mills FJ. Aviation medicine. Problems of altitude 1: hypoxia and hyperventilation. Br Med J (Clin Res Ed), 1983, 286(6375): 1408-1410.
|
| 10. |
Nicholson TT, Sznajder JI. Fitness to fly in patients with lung disease. Ann Am Thorac Soc, 2014, 11(10): 1614-1622.
|
| 11. |
Mohr LC. The hypoxia altitude simulation test: an increasingly performed test for the evaluation of patients prior to air travel. Chest, 2008, 133(4): 839-842.
|
| 12. |
Gong H Jr, Tashkin DP, Lee EY, et al. Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction. Am Rev Respir Dis, 1984, 130(6): 980-986.
|
| 13. |
Kelly PT, Swanney MP, Seccombe LM, et al. Air travel hypoxemia vs. the hypoxia inhalation test in passengers with COPD. Chest, 2008, 133(4): 920-926.
|
| 14. |
Billings CG, Wei HL, Thomas P, et al. The prediction of in-flight hypoxaemia using non-liner equations. Respir Med, 2013, 107(6): 841-847.
|
| 15. |
Balfour-Lynn IM. Hypoxic challenge test for airflight in children with respiratory disease. Paediatr Respir Rev, 2017, 21: 62-64.
|
| 16. |
Bagshaw M. Telemedicine in British airways. J Telemed Telecare, 1996, (2 Suppl): 36-38.
|
| 17. |
王建智, 劉立, 郭俊, 等. 商業航空飛行中的緊急醫學事件. 中華航空航天醫學雜志, 2006, 17(3): 237-241.
|
| 18. |
Aker? A, Edvardsen A, Christensen CC, et al. COPD and air travel: oxygen equipment and preflight titration of supplemental oxygen. Chest, 2011, 140(1): 84-90.
|
| 19. |
Edvardsen A, Aker? A, Hardie JA, et al. High prevalence of respiratory symptoms during air travel in patients with COPD. Respir Med, 2011, 105(1): 50-56.
|
| 20. |
Coker RK, Shiner RJ, Partridge MR. Is air travel safe for those with lung disease?. Eur Respir J, 2007, 30(6): 1057-1063.
|
| 21. |
Aker? A, Christensen CC, Edvardsen A, et al. Pulse oximetry in the preflight evaluation of patients with chronic obstructive pulmonary disease. Aviat Space Environ Med, 2008, 79(5): 518-524.
|
| 22. |
Edvardsen A, Aker? A, Christensen CC, et al. Air travel and chronic obstructive pulmonary disease: a new algorithm for pre-flight evaluation. Thorax, 2012, 67(11): 964-969.
|
| 23. |
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Arch Bronconeumol, 2017, 53(3): 128-149.
|
| 24. |
Dillard TA, Moores LK, Bilello KL, et al. The preflight evaluation. A comparison of the hypoxia inhalation test with hypobaric exposure. Chest, 1995, 107(2): 352-357.
|
| 25. |
Aker? A, Christensen CC, Edvardsen A, et al. Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight. Eur Respir J, 2005, 25(4): 725-730.
|
| 26. |
Christensen CC, Ryg M, Refvem OK, et al. Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2, 438 m (8, 000 ft) altitude. Eur Respir J, 2000, 15(4): 635-639.
|
| 27. |
Bradi AC, Faughnan ME, Stanbrook MB, et al. Predicting the need for supplemental oxygen during airline flight in patients with chronic obstructive pulmonary disease: a comparison of predictive equations and altitude simulation. Can Respir J, 2009, 16(4): 119-124.
|
| 28. |
Chetta A, Castagnetti C, Aiello M, et al. Walking capacity and fitness to fly in patients with chronic respiratory disease. Aviat Space Environ Med, 2007, 78(8): 789-792.
|
| 29. |
Elborn JS. Cystic fibrosis. Lancet, 2016, 388(10059): 2519-2531.
|
| 30. |
Rose DM, Fleck B, Thews O, et al. Blood gas-analyses in patients with cystic fibrosis to estimate hypoxemia during exposure to high altitudes in a hypobaric-chamber. Eur J Med Res, 2000, 5(1): 9-12.
|
| 31. |
Fischer R, Lang SM, Brückner, et al. Lung function in adults with cystic fibrosis at altitude: impact on air travel. Eur Respir J, 2005, 25(4): 718-724.
|
| 32. |
Peckham D, Watson A, Pollard K, et al. Predictors of desaturation during formal hypoxic challenge in adult patients with cystic fibrosis. J Cyst Fibros, 2002, 1(4): 281-286.
|
| 33. |
Edvardsen E, Aker? A, Skj?nsberg OH, et al. Pre-flight evaluation of adult patients with cystic fibrosis: a cross-sectional study. BMC Res Notes, 2017, 10(1): 84.
|
| 34. |
Kamin W, Fleck B, Rose DM, et al. Predicting hypoxia in cystic fibrosis patients during exposure to high altitudes. J Cyst Fibros, 2006, 5(4): 223-228.
|
| 35. |
Ali M, Smith IE, Gulati A, et al. Hypoxic challenge assessment in individuals with obstructive sleep apnea. Sleep Med, 2011, 12(2): 158-162.
|
| 36. |
李靜, 王菡僑, 徐茂人, 等. 肥胖低通氣綜合征. 臨床薈萃, 2016, 31(12): 1295-1297.
|
| 37. |
Ali M, Smith IE, Gulati A, et al. Pre-flight assessment in patients with obesity hypoventilation syndrome. Respirology, 2014, 19(8): 1229-1232.
|
| 38. |
蔡柏薔, 李龍云, 主編. 協和呼吸病學. 第2版. 北京: 中國協和醫科大學出版社, 2011, 1409.
|
| 39. |
Seccombe LM, Kelly PT, Wong CK, et al. Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease. Thorax, 2004, 59(11): 966-970.
|
| 40. |
Barratt SL, Shaw J, Jones R, et al. Physiological predictors of hypoxic challenge testing (HCT) outcomes in interstitial lung disease (ILD). Respir Med, 2018, 135: 51-56.
|